Cellceutix Corp. (CTIX.OB) Expedites Autism Studies in Response to Public Support; Announces Completion of Two Required Safety Pharmacology Studies
Cellceutix Corp. was pleased to announce this morning its acknowledgement of the many emails, phone calls and letters received regarding…